3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Carcinoma, Non-Small-Cell Lung
13
Multiple Myeloma
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma
11
Hodgkin Disease
11
Lymphoma, Non-Hodgkin
10
Lymphoma, Follicular
8
Neoplasms
7
Lymphoma, Mantle-Cell
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Burkitt Lymphoma
7
Breast Neoplasms
7
Unspecified Adult Solid Tumor, Protocol Specific
6
Recurrence
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Blast Crisis
6
Sezary Syndrome
5
Prostatic Neoplasms
5
Myeloproliferative Disorders
5
Myelodysplastic Syndromes
5
Mycosis Fungoides
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma, Large-Cell, Anaplastic
5
Lymphoma, Extranodal NK-T-Cell
5
Lymphoma, B-Cell, Marginal Zone
5
Brain Neoplasms
5
Interventions
Cyclophosphamide
4
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
fludarabine
2
Thiotepa
2
Peripheral Blood Stem Cell Transplantation
2
Mesna
2
Melphalan
2
Etoposide
2
Busulfan
2
sargramostim
1
regorafenib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
fludarabine phosphate
1
codrituzumab
1
Vorinostat
1
Vincristine
1
Topotecan
1
Temozolomide
1
Stem Cell Transplantation
1
Sirolimus
1
Simvastatin
1
Radiotherapy, Intensity-Modulated
1
Irinotecan
1
Ifosfamide
1
Gemcitabine
1
Carboplatin
1
Bone Marrow Transplantation
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Hepatoblastoma
×
Vorinostat
×
Clear all
NCT04308330
2026-04-15
NYMC195
New York Medical College
Phase 1
Recruiting
30 enrolled